CHMP meeting highlights: April 2024
European Pharmaceutical Review
APRIL 30, 2024
Last week, the US FDA approved a new gene therapy for eligible adults with haemophilia B. The committee also recommended the biosimilar medicine Wezenla (ustekinumab) to treat of plaque psoriasis. Generic medicine Eribulin Baxter (eribulin) was also granted a positive opinion by the committee, to treat breast cancer and liposarcoma.
Let's personalize your content